NewswireToday - /newswire/ -
San Jose, CA, United States, 2007/03/25 - With core competencies in both antibody production and detection reagents, AnaSpec provides a multi-platform technology base that is well-suited for the production of labeled secondary antibodies.
In the marketplace for labeled secondary antibodies, most companies offer experience in either antibody technologies or labeling technologies. With core competencies in both antibody production and detection reagents, AnaSpec provides a multi-platform technology base that is well-suited for the production of labeled secondary antibodies.
AnaSpec has established a worldwide reputation for providing high-quality AP-, HRP-conjugated and biotinylates secondary antibodies on the market. Leveraging its proprietary fluorescence technologies, AnaSpec line of labeled secondary antibodies includes antibodies labeled with fluorescent reagents with the industry’s highest photostability.
AnaSpec offers secondary antibodies labeled with its proprietary HiLyte Fluor dyes (Cy and Alexa dyes analogs) as well as secondary antibodies labeled with classic fluorophores like TAMRA, AMCA, FAM, and FITC.
About AnaSpec, Inc.
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.
AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development.
Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA. AnaSpec maintains ISO9001 certification, holds a California Drug Manufacturing License and a FDA Registration for GMP Drug Manufacturing.